Ligand validation:3CC9

GRG: GERANYLGERANYL DIPHOSPHATE

GRG is a Ligand Of Interest in 3CC9 designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
3CC9_GRG_A_501	61%	0%	0.171	0.959	3.02	7.36	7	12	2	0	100%	1
3CC9_GRG_B_501	51%	0%	0.209	0.963	2.99	6.9	7	12	2	0	100%	1
3CC9_GRG_C_501	40%	0%	0.215	0.939	3.12	7.97	7	11	0	0	93%	0.931
3CC9_GRG_D_501	15%	0%	0.369	0.933	2.96	6.54	7	10	1	0	100%	0.6552
3PH7_GRG_A_1502	60%	0%	0.188	0.976	3.05	7.94	7	12	3	0	100%	1
4OPD_GRG_B_502	99%	42%	0.047	0.987	0.67	1.57	-	6	2	0	100%	0.9
2E8V_GRG_B_1502	86%	26%	0.088	0.957	1.84	1.18	8	5	0	0	100%	1
3PZ2_GRG_B_334	78%	16%	0.138	0.981	2.09	1.65	11	5	2	0	100%	1
1N4S_GRG_J_1505	76%	57%	0.12	0.958	0.77	0.89	-	1	1	0	100%	1
2Z4V_GRG_A_1401	73%	27%	0.141	0.968	1.83	1.14	8	3	1	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.